Topics

Richard Sackler Sought to ‘Play Down’ Risk Concerns of OxyContin: Report

19:00 EST 3 Dec 2019 | BioSpace

Richard Sackler, the former president of Purdue Pharma, wanted prescribers to know that when it comes to treating pain, OxyContin was the way to go. And, in order to boost those sales, that meant the company had to downplay any concerns regarding the risk of addiction.

Original Article: Richard Sackler Sought to ‘Play Down’ Risk Concerns of OxyContin: Report

NEXT ARTICLE

More From BioPortfolio on "Richard Sackler Sought to ‘Play Down’ Risk Concerns of OxyContin: Report"

Quick Search

Relevant Topics

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...